ARTICLE | Company News
Apricus Biosciences, Stellar Pharmaceuticals sales and marketing update
January 9, 2012 8:00 AM UTC
Apricus granted Stellar exclusive rights to commercialize MycoVa in Canada to treat onychomycosis. Apricus will receive an undisclosed upfront payment and is eligible for milestones and tiered double...